ARMGO Pharma, Inc.
8Patents
8Active
8Granted
58Portfolio score
Filing activity: Nov 11, 2013 → Jul 25, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8853198B2 | Agents for treating disorders involving modulation of ryanodine receptors | Chemistry; Metallurgy | 4 | Active |
| US11504383B2 | Crystalline forms of a Ryanodine receptor modulator and uses thereof | Human Necessities | 2 | Active |
| US12161650B2 | Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof | Human Necessities | 0 | Active |
| US12059426B2 | Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof | Human Necessities | 0 | Active |
| US12076327B2 | Crystalline forms of a ryanodine receptor modulator and uses thereof | Human Necessities | 0 | Active |
| US12076326B2 | Crystalline forms of a ryanodine receptor modulator and uses thereof | Human Necessities | 0 | Active |
| US9573914B2 | Process for preparing benzothiazepines from gamma-aminoalkylbenzenes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11717526B2 | Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.